Phase I trial of the poly(ADP-ribose) polymerase (PARP) inhibitor olaparib and AKT inhibitor capivasertib in patients with BRCA1/2 and non-BRCA1/2 mutant cancers
scientific article published on 12 June 2020
Author/s
author: Timothy A Yap, Rebecca Kristeleit, Stephen J Pettitt, Susana Miranda, Ruth Matthews, Nina Tunariu, Ruth Ruddle, Shaun A Decordova, Karen E Swales, Emma Hall, Justin Lindemann, Udai Banerji, Bristi Basu, Yvette Drew
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.